Ignite Creation Date:
2025-12-24 @ 9:31 PM
Ignite Modification Date:
2025-12-25 @ 7:16 PM
Study NCT ID:
NCT00297232
Status:
TERMINATED
Last Update Posted:
2016-07-15
First Post:
2006-02-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Natalizumab (Tysabri) Re-Initiation of Dosing
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03
Start Date Type:
None
Primary Completion Date:
2014-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-27
First Submit QC Date:
None
Study First Post Date:
2006-02-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-21
Results First Submit QC Date:
None
Results First Post Date:
2015-05-29
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-16
Last Update Post Date:
2016-07-15
Last Update Post Date Type:
ESTIMATED